Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Mycol Med ; 33(3): 101409, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37354816

ABSTRACT

The increasing incidences of fungal infections among Covid-19 infected patients is a global public concern and urgently demands novel antifungals. Biopolymers like chitosan hold unique structural properties and thus can be utilized in the synthesis of biologically important scaffolds. To address the current scenario, the author's synthesized novel chitosan-azetidine derivative by adopting one-pot multicomponent reaction approach. The influence of chemical modification on the structural characteristics was investigated by means of spectroscopic techniques viz. FT-IR and 1HNMR and elemental analysis. Additionally, the authors investigated the antifungal potential of chitosan-azetidine derivative against Aspergillus fumigatus 3007 and the results indicated higher antifungal effect with an antifungal inhibitory index of 26.19%. The SEM and confocal microscopy images also reflected a significant inhibitory effect on the morphology of fungal mycelia, thus reflecting the potential of synthesized chitosan-azetidine derivativeas a potential antifungal agent.


Subject(s)
Azetidines , COVID-19 , Chitosan , Humans , Antifungal Agents/chemistry , Chitosan/pharmacology , Chitosan/chemistry , Spectroscopy, Fourier Transform Infrared
2.
J Mycol Med ; 30(1): 100910, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31806380

ABSTRACT

The fungal diseases represent an increasing global health burden and have transformed from a rare curiosity to the leading cause of human mortality. The present manuscript reports the antifungal potential of two novel compounds possessing a carbohydrate and an imidazole moiety. Antifungal susceptibility test determined the growth inhibition potential of the synthesized compounds against Aspergillus niger 9689 and it was observed that compounds D and E gave an antifungal inhibitory index of 66.66 and 56.67% respectively. Further, ultra-structure analysis of the treated fungal mycelia through scanning electron microscope (SEM) and confocal microscopy indicated significant membrane permeability and disintegration of fungal cell membrane, thus highlighting the probable role of the synthesized compounds as inhibitors of fungal lanosterol 14α-demethylase. In silico studies corroborated with the in-vitro results, as the synthesized compounds interacted with the critical amino acids present at the active site of the fungal enzyme (lanosterol 14α-demethylase).


Subject(s)
Antifungal Agents , Carbohydrates/chemistry , Cell Membrane/drug effects , Imidazoles/chemistry , 14-alpha Demethylase Inhibitors/chemical synthesis , 14-alpha Demethylase Inhibitors/chemistry , 14-alpha Demethylase Inhibitors/pharmacology , Antifungal Agents/chemical synthesis , Antifungal Agents/chemistry , Antifungal Agents/pharmacology , Aspergillus niger/drug effects , Aspergillus niger/ultrastructure , Carbohydrate Sequence/physiology , Cell Membrane Permeability/drug effects , Humans , Imidazoles/chemical synthesis , Imidazoles/pharmacology , Microbial Sensitivity Tests , Models, Molecular , Molecular Docking Simulation , Molecular Structure , Sterol 14-Demethylase/metabolism , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...